You are here

Home » Reports

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 1 - 10 of 574 results
 
  • Record 1 TO 574

  1. VASCULAR STAPLER

    SBC: ABIOMED, INC.            Topic: N/A

    THE OBJECTIVE OF THIS PROGRAM IS TO DESIGN AND BUILD A STAPLER FOR PERFORMING END-TO-END AND END-TO-SIDE ANASTOMOSES ON MEDIUM TO LARGE VESSELS, AND FOR REPAIRING BLOOD VESSELS AND VASCULAR ANEURYSMS, AND TO DEVELOP A SURGICAL PROTOCOL FOR ITS USE. THE METHOD PROPOSED USES A SPECIAL STAPLER AND CONFIGURATION OF STAPLES WHICH MINIMIZESBLOOD CONTACT WITH THE STAPLES, DOES NOT RESTRICT THE FLOW OF BL ...

    SBIR Phase I 1988 Department of Health and Human Services

  2. ULTRAMINIATURE IMPLANTABLE ELECTRICAL CONNECTOR

    SBC: ABIOMED, INC.            Topic: N/A

    N/A

    SBIR Phase I 1988 Department of Health and Human Services

  3. Anastomotic Device for Large Vascular Grafts

    SBC: ABIOMED, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The objective of this proposed program is to develop a general purpose anastomotic device for large vessels and vascular grafts, based on a novel stapler design. The use of the device can provide an alternative procedure to the current manual suturing methods, with the potential of yielding anastomoses having better and more reproducible performance, and with r ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health

  4. Intraventricular Cardiac Assist System for Decompression and Recovery

    SBC: ABIOMED, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The overall objective of this proposed program is the commercialization of an advanced intraventricular cardiac assist system for cardiac unloading and recovery. This type of ventricular assist device (VAD) will provide the optimal support for recovery for acute heart failure patients, and may be useful for a select group of chronic heart failure patients suppo ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health

  5. A BIOMATERIAL FOR ESOPHAGEAL REPAIR

    SBC: ACELL, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): ACell is a tissue engineering company and its core technology is based upon a porcine derived extracellular matrix (ECM) harvested from the urinary bladder (UBM) that serves as a constructive scaffold for tissue reconstruction. Successful completion of Phase I studies showed that the UBM-ECM can be configured into a tube shaped device with mechanical and materi ...

    SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health

  6. NOVEL CATHETER FOR TREATMENT OF VENTRICULAR TACHYCARDIA

    SBC: Thermedical Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Sudden cardiac death kills 300,000 people in the United States yearly. More than half of these deaths are caused by arrhythmias including ventricular tachycardia. Radiofrequency ablation, which successfully treats supraventricular tachycardia, is not successful at treating ventricular tachycardia because conventional RF ablation catheters cannot treat a large e ...

    SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health

  7. HUMAN MONOCOLONAL ANTIBODIES FOR CNS REMYELINATION

    SBC: Acorda Therapeutics, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): The primary goal of the current research will be to select the best recombinant form of one of two naturally occurring human igM antibodies demonstrated to stimulate remyelination to further develop for clinical testing in inflammatory demyelinating disease, such as MS. These antibodies, designated sHIgM22 and sHIgM46, were isolated by the Rodriquez laboratory ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health

  8. SECRETED PROTEIN FROM ADIPOCYTES AND PREADIPOCYTES

    SBC: ADIPOGENIX, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Obesity is a well-established risk factor for a number of diseases, including type 2 diabetes and coronary heart disease. While weight loss is the most effective treatment of type 2 diabetes, current methods for reducing weight are typically insufficient for long-term weight loss. The mission of AdipoGenix, Inc. is to discover, develop, and license novel therap ...

    SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health

  9. HEPATOCYTE DIRECTED MAGNETIC RESONANCE CONTRAST AGENTS

    SBC: ADVANCED MAGNETICS, INC.            Topic: N/A

    N/A

    SBIR Phase I 1988 Department of Health and Human Services

  10. METAL REPRESSOR TARGETS AND PEPTIDE ACTIVATORS

    SBC: ADVANCED MICROBIAL SOLUTIONS CORPORATION            Topic: N/A

    It is becoming more difficult to treat bacterial infections such as, tuberculosis, staphylococcus, and streptococcus due to the emergence of multiple antibiotic-resistant strains. Rational drug design may prove invaluable for developing new antibiotic agents. Advanced Microbial Solutions Corporation (AMS) developing a new class of anti-microbial agents targeted at metal ion-activated transcription ...

    SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government